Neuroectodermal Tumors × NET × Clear all
NCT03093116 2025-07-10

TRIDENT-1

Turning Point Therapeutics, Inc.

Phase 1/2 Recruiting
500 enrolled 2 FDA
NCT03037385 2025-05-31

ARROW

Hoffmann-La Roche

Phase 1/2 Completed
590 enrolled 58 charts 5 FDA
NCT04949282 2022-12-23

SEPTRALU

Sociedad Española de Medicina Nuclear e Imagen Molecular

Recruiting
5,000 enrolled
NCT01177007 2017-08-28

Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors

Yale University

Phase 2 Completed
50 enrolled 10 charts
NCT01215578 2015-04-30

NET

Assistance Publique - Hôpitaux de Paris

Phase 2 Terminated
33 enrolled
NCT00753415 2015-03-17

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Merck Sharp & Dohme LLC

Phase 1 Completed
37 enrolled 10 charts